BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Desai M, Saligram S, Gupta N, Vennalaganti P, Bansal A, Choudhary A, Vennelaganti S, He J, Titi M, Maselli R, Qumseya B, Olyaee M, Waxman I, Repici A, Hassan C, Sharma P. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis. Gastrointest Endosc 2017;85:482-495.e4. [PMID: 27670227 DOI: 10.1016/j.gie.2016.09.022] [Cited by in Crossref: 104] [Cited by in F6Publishing: 109] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Bahdi F, Katti CC, Mansour N, Gagneja H, Anandasabapathy S, Othman MO. Outcomes of endoscopic submucosal dissection (ESD) plus radiofrequency ablation (RFA) for nodular Barrett's esophagus. Scand J Gastroenterol 2023;58:123-32. [PMID: 35968576 DOI: 10.1080/00365521.2022.2111226] [Reference Citation Analysis]
2 Stawinski PM, Dziadkowiec KN, Kuo LA, Echavarria J, Saligram S. Barrett's Esophagus: An Updated Review. Diagnostics (Basel) 2023;13. [PMID: 36673131 DOI: 10.3390/diagnostics13020321] [Reference Citation Analysis]
3 Weiss S, Pellat A, Corre F, Abou Ali E, Belle A, Terris B, Leconte M, Dohan A, Chaussade S, Coriat R, Barret M. Predictive factors of radiofrequency ablation failure in the treatment of dysplastic Barrett's esophagus. Clin Res Hepatol Gastroenterol 2023;47:102065. [PMID: 36494071 DOI: 10.1016/j.clinre.2022.102065] [Reference Citation Analysis]
4 van Munster SN, Nieuwenhuis E, Bisschops R, Willekens H, Weusten BLAM, Herrero LA, Bogte A, Alkhalaf A, Schenk EBE, Schoon EJ, Curvers W, Koch AD, de Jonge PJF, Tang TJ, Nagengast WB, Westerhof J, Houben MHMG, Bergman JJGHM, Pouw RE. Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early Neoplasia. Clin Gastroenterol Hepatol 2022;20:2495-2504.e5. [PMID: 35292379 DOI: 10.1016/j.cgh.2022.02.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mittal C, Muthusamy VR, Simon VC, Brauer BC, Mullady DK, Hollander T, Sloan I, Kushnir V, Early D, Rastogi A, Hammad HT, Edmundowicz SA, Han S, Thaker AM, Ezekwe E, Wani S, Kwasny MJ, Komanduri S. Threshold evaluation for optimal number of endoscopic treatment sessions to achieve complete eradication of Barrett's metaplasia. Endoscopy 2022;54:927-33. [PMID: 35135015 DOI: 10.1055/a-1765-7197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Overwater A, Elias SG, Schoon EJ, Bergman JJGHM, Pouw RE, Weusten BLAM. The course of pain and dysphagia after radiofrequency ablation for Barrett's esophagus-related neoplasia. Endoscopy 2022. [PMID: 36070753 DOI: 10.1055/a-1929-1448] [Reference Citation Analysis]
7 Sharma P. Barrett Esophagus: A Review. JAMA 2022;328:663-71. [PMID: 35972481 DOI: 10.1001/jama.2022.13298] [Reference Citation Analysis]
8 Emura F, Chandrasekar VT, Hassan C, Armstrong D, Messmann H, Arantes V, Araya R, Barrera-Leon O, Bergman JJGHM, Bandhari P, Bourke MJ, Cerisoli C, Chiu PW, Desai M, Dinis-Ribeiro M, Falk GW, Fujishiro M, Gaddam S, Goda K, Gross S, Haidry R, Ho L, Iyer PG, Kashin S, Kothari S, Lee YY, Matsuda K, Neuhaus H, Oyama T, Ragunath K, Repici A, Shaheen N, Singh R, Sobrino-Cossio S, Wang KK, Waxman I, Sharma P. Rio de Janeiro Global Consensus on Landmarks, Definitions, and Classifications in Barrett's Esophagus: World Endoscopy Organization Delphi Study. Gastroenterology 2022;163:84-96.e2. [PMID: 35339464 DOI: 10.1053/j.gastro.2022.03.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Thota PN, Sanaka MR. How I Do It: ESD Versus EMR for EAC. Foregut 2022;2:196-200. [DOI: 10.1177/26345161221110212] [Reference Citation Analysis]
10 Maione F, Chini A, Maione R, Manigrasso M, Marello A, Cassese G, Gennarelli N, Milone M, De Palma GD. Endoscopic Diagnosis and Management of Barrett's Esophagus with Low-Grade Dysplasia. Diagnostics (Basel) 2022;12:1295. [PMID: 35626450 DOI: 10.3390/diagnostics12051295] [Reference Citation Analysis]
11 Kolb JM, Wani S. Endoscopic Management of Barrett's Esophagus. Dig Dis Sci 2022;67:1469-79. [PMID: 35226224 DOI: 10.1007/s10620-022-07395-x] [Reference Citation Analysis]
12 Daroudi R, Nahvijou A, Arab M, Faramarzi A, Kalaghchi B, Sari AA, Javan-noughabi J. A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma. Cost Eff Resour Alloc 2022;20. [DOI: 10.1186/s12962-022-00352-5] [Reference Citation Analysis]
13 Agarwal S, Alshelleh M, Scott J, Dhaliwal L, Codipilly DC, Dierkhising R, Leggett CL, Wang KK, Otaki FA, Trindade AJ, Iyer PG. Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study. Gastrointest Endosc 2022;95:422-431.e2. [PMID: 34624303 DOI: 10.1016/j.gie.2021.09.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Wang Y, Ma B, Yang S, Li W, Li P. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett’s Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials. Front Oncol 2022;12:801940. [DOI: 10.3389/fonc.2022.801940] [Reference Citation Analysis]
15 Pilonis ND, Killcoyne S, Tan WK, O'Donovan M, Malhotra S, Tripathi M, Miremadi A, Debiram-Beecham I, Evans T, Phillips R, Morris DL, Vickery C, Harrison J, di Pietro M, Ortiz-Fernandez-Sordo J, Haidry R, Kerridge A, Sasieni PD, Fitzgerald RC. Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot. Lancet Oncol 2022;23:270-8. [PMID: 35030332 DOI: 10.1016/S1470-2045(21)00667-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
16 van Munster S, Nieuwenhuis E, Weusten BLAM, Alvarez Herrero L, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, van de Ven SEM, de Jonge PJF, Tang TJ, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJ, Pouw RE; Dutch Barrett Expert Centers. Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period. Gut 2022;71:265-76. [PMID: 33753417 DOI: 10.1136/gutjnl-2020-322615] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 32.0] [Reference Citation Analysis]
17 Konda VJ, Ellison A, Codipilly DC, Han J, Samarasena J, Iyer PG. Quality in Barrett's Esophagus: Diagnosis and Management. Techniques and Innovations in Gastrointestinal Endoscopy 2022. [DOI: 10.1016/j.tige.2022.01.009] [Reference Citation Analysis]
18 Ehlken H, Schmitz R, Riethdorf S, Riethdorf L, Krause J, Karstens KF, Schrader J, Viol F, Giannou A, Sterlacci W, Vieth M, Clauditz T, Kähler C, Mann O, Izbicki JR, Huber S, Pantel K, Rösch T. Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett's carcinoma. Gut 2022;71:277-86. [PMID: 33441377 DOI: 10.1136/gutjnl-2020-322723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Vantanasiri K, Iyer PG. State-of-the-art management of dysplastic Barrett's esophagus. Gastroenterology Report 2022;10. [DOI: 10.1093/gastro/goac068] [Reference Citation Analysis]
20 Knabe M, Beyna T, Rösch T, Bergman J, Manner H, May A, Schachschal G, Neuhaus H, Kandler J, Weusten B, Pech O, Faiss S, Anders M, Vieth M, Sehner S, Bisschops R, Bhandari P, Ell C, Ehlken H. Hybrid APC in Combination With Resection for the Endoscopic Treatment of Neoplastic Barrett's Esophagus: A Prospective, Multicenter Study. Am J Gastroenterol 2022;117:110-9. [PMID: 34845994 DOI: 10.14309/ajg.0000000000001539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
21 Sokolov S, Pirogov S, Ryabov A, Fedorov E, Shveikin A, Lenskii B, Kanner D, Kaprin A. Possibilities of endoscopy in diagnosis and treatment of patients with early cardioesophageal cancer. Onkol Z im P A Gercena 2022;11:68. [DOI: 10.17116/onkolog20221102168] [Reference Citation Analysis]
22 Longcroft-wheaton G, Alkandari A, Bhandari P. Esophageal Neoplasia: Endoscopic Diagnosis and Treatment. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2022. [DOI: 10.1007/978-3-030-56993-8_3] [Reference Citation Analysis]
23 Pokala SK, Jones B, Wani S. Quality in Advanced Endoscopy. Techniques and Innovations in Gastrointestinal Endoscopy 2022;24:300-308. [DOI: 10.1016/j.tige.2022.01.004] [Reference Citation Analysis]
24 Chang K, Jackson CS, Vega KJ. Barrett's Esophagus: Diagnosis, Management, and Key Updates. Gastroenterol Clin North Am 2021;50:751-68. [PMID: 34717869 DOI: 10.1016/j.gtc.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Othman MO, Bahdi F, Ahmed Y, Gagneja H, Andrawes S, Groth S, Dhingra S. Short-term clinical outcomes of non-curative endoscopic submucosal dissection for early esophageal adenocarcinoma. Eur J Gastroenterol Hepatol 2021;33:e700-8. [PMID: 34091478 DOI: 10.1097/MEG.0000000000002223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Ventre S, Shahid H. Endoscopic therapies for Barrett's esophagus. Transl Gastroenterol Hepatol 2021;6:62. [PMID: 34805584 DOI: 10.21037/tgh.2020.02.04] [Reference Citation Analysis]
27 Desai M, Rösch T, Sundaram S, Chandrasekar VT, Kohli D, Spadaccini M, Hassan C, Repici A, Sharma P. Systematic review with meta-analysis: the long-term efficacy of Barrett's endoscopic therapy-stringent selection criteria and a proposal for definitions. Aliment Pharmacol Ther 2021;54:222-33. [PMID: 34165205 DOI: 10.1111/apt.16473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Staudenmann DA, Skacel EP, Tsoutsman T, Kaffes AJ, Saxena P. Safety and long-term efficacy of hybrid-argon plasma coagulation for the treatment of Barrett's esophagus: An Australian pilot study (with video). Int J Gastrointest Interv 2021;10:128-32. [DOI: 10.18528/ijgii200050] [Reference Citation Analysis]
29 Elias PS, Spechler SJ. Barrett's Esophagus. The Esophagus 2021. [DOI: 10.1002/9781119599692.ch29] [Reference Citation Analysis]
30 Zhang L, Sun B, Zhou X, Wei Q, Liang S, Luo G, Li T, Lü M. Barrett's Esophagus and Intestinal Metaplasia. Front Oncol 2021;11:630837. [PMID: 34221959 DOI: 10.3389/fonc.2021.630837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yang H, Hu B. Recent advances in early esophageal cancer: diagnosis and treatment based on endoscopy. Postgrad Med 2021;133:665-73. [PMID: 34030580 DOI: 10.1080/00325481.2021.1934495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
32 Solfisburg QS, Sami SS, Gabre J, Soroush A, Dhaliwal L, Beveridge C, Jin Z, Poneros JM, Falk GW, Ginsberg GG, Wang KK, Lightdale CJ, Iyer PG, Abrams JA. Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2021;93:1250-1257.e3. [PMID: 33144238 DOI: 10.1016/j.gie.2020.10.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
33 Barret M, Pioche M, Terris B, Ponchon T, Cholet F, Zerbib F, Chabrun E, Le Rhun M, Coron E, Giovannini M, Caillol F, Laugier R, Jacques J, Legros R, Boustiere C, Rahmi G, Metivier-Cesbron E, Vanbiervliet G, Bauret P, Escourrou J, Branche J, Jilet L, Abdoul H, Kaddour N, Leblanc S, Bensoussan M, Prat F, Chaussade S. Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial. Gut 2021;70:1014-22. [PMID: 33685969 DOI: 10.1136/gutjnl-2020-322082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
34 Kumar P, Gordon IO, Thota PN. Post-ablation buried neoplasia in Barrett's esophagus. Scand J Gastroenterol 2021;56:624-8. [PMID: 33764825 DOI: 10.1080/00365521.2021.1896774] [Reference Citation Analysis]
35 Jaruvongvanich V, Osman K, Matar R, Baroud S, Hanada Y, Chesta FNU, Maselli DB, Mahmoud T, Wang KK, Abu Dayyeh BK. Impact of bariatric surgery on surveillance and treatment outcomes of Barrett's esophagus: A stage-matched cohort study. Surg Obes Relat Dis 2021;17:1457-64. [PMID: 34083137 DOI: 10.1016/j.soard.2021.04.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Boškoski I, Hamanaka J, Barbaro F, Arena V, Mascagni P, Caristo ME, De Siena M, Gallo C, Costamagna G. Feasibility and safety of a new endoscopic synthetic sealant nebulizing device over gastric endoscopic submucosal dissections. Surg Endosc 2021;35:4048-54. [PMID: 33851265 DOI: 10.1007/s00464-021-08480-4] [Reference Citation Analysis]
37 Li Y, Xiao W, Gao Z. A systematic review and meta-analysis of radio frequency ablation and routine resection in the treatment of small hepatocellular carcinoma. J Gastrointest Oncol 2021;12:770-80. [PMID: 34012665 DOI: 10.21037/jgo-21-52] [Reference Citation Analysis]
38 Kahn A, Priyan H, Dierkhising RA, Johnson ML, Lansing RM, Maixner KA, Wolfsen HC, Wallace MB, Ramirez FC, Fleischer DE, Leggett CL, Wang KK, Iyer PG. Outcomes of radiofrequency ablation by manual versus self-sizing circumferential balloon catheters for the treatment of dysplastic Barrett's esophagus: a multicenter comparative cohort study. Gastrointest Endosc 2021;93:880-887.e1. [PMID: 32739482 DOI: 10.1016/j.gie.2020.07.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dhaliwal L, Iyer PG. State of the Art: Management of Barrett’s Esophagus Related Dysplasia and Neoplasia—Which Patient and What Therapy? Foregut 2021;1:68-77. [DOI: 10.1177/2634516121993260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
41 Pendleton AC, Scott Melvin W. Ablative Therapies in Barrett’s Esophagus. Benign Esophageal Disease 2021. [DOI: 10.1007/978-3-030-51489-1_18] [Reference Citation Analysis]
42 Goda K, Takeuchi M, Ishihara R, Fujisaki J, Takahashi A, Takaki Y, Hirasawa D, Momma K, Amano Y, Yagi K, Furuhashi H, Hashimoto S, Kanesaka T, Shimizu T, Ono Y, Yamagata T, Fujiwara J, Azumi T, Watanabe G, Ohkura Y, Nishikawa M, Oyama T. Diagnostic utility of a novel magnifying endoscopic classification system for superficial Barrett's esophagus-related neoplasms: a nationwide multicenter study. Esophagus 2021;18:713-23. [PMID: 34052965 DOI: 10.1007/s10388-021-00841-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 van Munster SN, Nieuwenhuis EA, Weusten BLAM, Herrero LA, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, van de Ven SEM, de Jonge PJF, Tang T, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJGHM, Pouw RE; Dutch Barrett Expert Centers. Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term Mortality. J Gastrointest Surg 2021;25:67-76. [PMID: 33140322 DOI: 10.1007/s11605-020-04836-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Longcroft-wheaton G, Alkandari A, Bhandari P. Esophageal Neoplasia: Endoscopic Diagnosis and Treatment. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2021. [DOI: 10.1007/978-3-030-29964-4_3-1] [Reference Citation Analysis]
45 Farina DA, Condon A, Komanduri S, Muthusamy VR. A Practical Approach to Refractory and Recurrent Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:183-203. [PMID: 33213795 DOI: 10.1016/j.giec.2020.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Leclercq P, Bisschops R. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability. Gastrointest Endosc Clin N Am 2021;31:131-54. [PMID: 33213792 DOI: 10.1016/j.giec.2020.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Jackson T, Faugno-fusci D, Wogsland A, Marks J. Endoscopic Mucosal Resection. Benign Esophageal Disease 2021. [DOI: 10.1007/978-3-030-51489-1_19] [Reference Citation Analysis]
48 Kumarasinghe MP, Armstrong M, Foo J, Raftopoulos SC. The modern management of Barrett's oesophagus and related neoplasia: role of pathology. Histopathology 2021;78:18-38. [PMID: 33382493 DOI: 10.1111/his.14285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
49 Pech O. Barrett-Ösophagus. Gastroenterologie up2date 2020;16:351-364. [DOI: 10.1055/a-1102-9904] [Reference Citation Analysis]
50 Shimamura Y, Iwaya Y, Kobayashi R, Rodriguez de Santiago E, Muwanwella N, Raftopoulos S, Mosko JD, May GR, Kandel G, Kortan P, Marcon N, Teshima CW. Clinical and pathological predictors of failure of endoscopic therapy for Barrett's related high-grade dysplasia and early esophageal adenocarcinoma. Surg Endosc 2021;35:5468-79. [PMID: 32989547 DOI: 10.1007/s00464-020-08037-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
51 Dam AN, Klapman J. A narrative review of Barrett's esophagus in 2020, molecular and clinical update.Ann Transl Med. 2020;8:1107. [PMID: 33145326 DOI: 10.21037/atm-20-4406] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
52 Badgery H, Read M, Winter NN, Taylor ACF, Hii MW. The role of esophagectomy in the management of Barrett's esophagus with high-grade dysplasia. Ann N Y Acad Sci 2020;1481:72-89. [PMID: 32812261 DOI: 10.1111/nyas.14439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Pech O, Alqahtani SA. Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia. Ther Adv Gastrointest Endosc 2020;13:2631774520935241. [PMID: 32783025 DOI: 10.1177/2631774520935241] [Reference Citation Analysis]
54 Furnari M, Telese A, Hann A, Lisotti A, Boškoski I, Eusebi LH. New Devices for Endoscopic Treatments in Gastroenterology: A Narrative Review. Curr Drug Metab 2020;21:850-65. [PMID: 32703127 DOI: 10.2174/1389200221666200722145727] [Reference Citation Analysis]
55 Vermeulen BD, van der Leeden B, Ali JT, Gudbjartsson T, Hermansson M, Low DE, Adler DG, Botha AJ, D'Journo XB, Eroglu A, Ferri LE, Gubler C, Haveman JW, Kaman L, Kozarek RA, Law S, Loske G, Lindenmann J, Park JH, Richardson JD, Salminen P, Song HY, Søreide JA, Spaander MCW, Tarascio JN, Tsai JA, Vanuytsel T, Rosman C, Siersema PD; Benign Esophageal Perforation Collaborative Group. Early diagnosis is associated with improved clinical outcomes in benign esophageal perforation: an individual patient data meta-analysis. Surg Endosc 2021;35:3492-505. [PMID: 32681374 DOI: 10.1007/s00464-020-07806-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
56 Alzoubaidi D, Hussein M, Sehgal V, Makahamadze C, Magee CG, Everson M, Graham D, Sweis R, Banks M, Sami SS, Novelli M, Lovat L, Haidry R. Cryoballoon ablation for treatment of patients with refractory esophageal neoplasia after first line endoscopic eradication therapy. Endosc Int Open 2020;8:E891-9. [PMID: 32665972 DOI: 10.1055/a-1149-1414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Ahmed Y, Othman M. EMR/ESD: Techniques, Complications, and Evidence. Curr Gastroenterol Rep 2020;22:39. [PMID: 32542462 DOI: 10.1007/s11894-020-00777-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
58 Kahn A, Shaheen NJ, Iyer PG. Approach to the Post-Ablation Barrett's Esophagus Patient. Am J Gastroenterol 2020;115:823-31. [PMID: 31899706 DOI: 10.14309/ajg.0000000000000514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
59 Barbieri L, Talavera Urquijo E, Parise P, Nilsson M, Reynolds JV, Rosati R. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency. Dis Esophagus 2020;33. [PMID: 32322892 DOI: 10.1093/dote/doaa028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
60 Franklin J, Jankowski J. Recent advances in understanding and preventing oesophageal cancer. F1000Res 2020;9:276. [DOI: 10.12688/f1000research.21971.1] [Reference Citation Analysis]
61 Genere JR, Priyan H, Sawas T, Hanada Y, Visrodia K, Zakko L, Iyer PG, Wong Kee Song LM, Wang KK. Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia. Gastrointest Endosc 2020;91:797-805. [PMID: 31870824 DOI: 10.1016/j.gie.2019.12.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
62 Shahidi N, van Hattem WA, Bourke MJ. Just relax: allowing the endoscopist and esophagus to "cool off" between radiofrequency ablation applications affects stricture formation. Gastrointest Endosc 2020;91:455-7. [PMID: 32036952 DOI: 10.1016/j.gie.2019.09.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review. Gastroenterology 2020;158:760-9. [PMID: 31730766 DOI: 10.1053/j.gastro.2019.09.051] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 31.7] [Reference Citation Analysis]
64 Hamel C, Ahmadzai N, Beck A, Thuku M, Skidmore B, Pussegoda K, Bjerre L, Chatterjee A, Dennis K, Ferri L, Maziak DE, Shea BJ, Hutton B, Little J, Moher D, Stevens A. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Syst Rev 2020;9:20. [PMID: 31996261 DOI: 10.1186/s13643-020-1275-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
65 Kumarasinghe MP, Bourke MJ, Brown I, Draganov PV, McLeod D, Streutker C, Raftopoulos S, Ushiku T, Lauwers GY. Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review. Mod Pathol 2020;33:986-1006. [PMID: 31907377 DOI: 10.1038/s41379-019-0443-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
66 Templeton A, Kaz A, Snider E, Grady WM. Barrett’s Esophagus: Diagnosis and Management. Esophageal Cancer 2020. [DOI: 10.1007/978-3-030-29832-6_4] [Reference Citation Analysis]
67 Singh T, Sanghi V, Thota PN. Current management of Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med 2019;86:724-32. [PMID: 31710585 DOI: 10.3949/ccjm.86a.18106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
68 Sanghi V, Amin H, Sanaka MR, Thota PN. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management. World J Gastrointest Endosc 2019; 11(10): 491-503 [PMID: 31798770 DOI: 10.4253/wjge.v11.i10.491] [Reference Citation Analysis]
69 Junquera F, Fernández-ananín S, Balagué C. Therapeutic Options for Early Cancer of the Esophagogastric Junction. Cirugía Española (English Edition) 2019;97:438-444. [DOI: 10.1016/j.cireng.2019.09.006] [Reference Citation Analysis]
70 Gockel I, Hoffmeister A. Endoscopic or Surgical Resection for Gastro-Esophageal Cancer. Dtsch Arztebl Int 2018;115:513-9. [PMID: 30149830 DOI: 10.3238/arztebl.2018.0513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
71 Omar M, Thaker AM, Wani S, Simon V, Ezekwe E, Boniface M, Edmundowicz S, Obuch J, Cinnor B, Brauer BC, Wood M, Early DS, Lang GD, Mullady D, Hollander T, Kushnir V, Komanduri S, Muthusamy VR. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy. Gastrointest Endosc 2019;90:395-403. [PMID: 31004598 DOI: 10.1016/j.gie.2019.04.216] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
72 Alzoubaidi D, Ragunath K, Wani S, Penman ID, Trudgill NJ, Jansen M, Banks M, Bhandari P, Morris AJ, Willert R, Boger P, Smart HL, Ravi N, Dunn J, Gordon C, Mannath J, Mainie I, di Pietro M, Veitch AM, Thorpe S, Magee C, Everson M, Sami S, Bassett P, Graham D, Attwood S, Pech O, Sharma P, Lovat LB, Haidry R. Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia. Frontline Gastroenterol 2020;11:259-71. [PMID: 32587669 DOI: 10.1136/flgastro-2019-101247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
73 Junquera F, Fernández-Ananín S, Balagué C. Therapeutic options for early cancer of the esophagogastric junction. Cir Esp (Engl Ed) 2019;97:438-44. [PMID: 31138450 DOI: 10.1016/j.ciresp.2019.04.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Peters Y, Al-kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 14.0] [Reference Citation Analysis]
75 Sawas T, Alsawas M, Bazerbachi F, Iyer PG, Wang KK, Murad MH, Katzka DA. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis. Gastrointest Endosc 2019;89:913-925.e6. [PMID: 30529044 DOI: 10.1016/j.gie.2018.11.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
76 Yang D, Othman M, Draganov PV. Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection For Barrett's Esophagus and Colorectal Neoplasia. Clin Gastroenterol Hepatol 2019;17:1019-28. [PMID: 30267866 DOI: 10.1016/j.cgh.2018.09.030] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 15.0] [Reference Citation Analysis]
77 Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA. Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses. Dig Dis Sci 2019;64:1089-97. [PMID: 30911864 DOI: 10.1007/s10620-019-05586-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
78 Honing J, Kievit W, Bookelaar J, Peters Y, Iyer PG, Siersema PD. Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett's esophagus in patients with GERD symptoms. Gastrointest Endosc 2019;89:712-722.e3. [PMID: 30385112 DOI: 10.1016/j.gie.2018.10.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
79 Furneri G, Klausnitzer R, Haycock L, Ihara Z. Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model. PLoS One 2019;14:e0212916. [PMID: 30865673 DOI: 10.1371/journal.pone.0212916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
80 Alzoubaidi D, Graham D, Bassett P, Magee C, Everson M, Banks M, Novelli M, Jansen M, Lovat LB, Haidry R. Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia. Surg Endosc 2019;33:3665-72. [PMID: 30671663 DOI: 10.1007/s00464-018-06655-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
81 Pollit V, Graham D, Leonard C, Filby A, McMaster J, Mealing SJ, Lovat LB, Haidry RJ. A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett's oesophagus in the United Kingdom. Curr Med Res Opin 2019;35:805-15. [PMID: 30479169 DOI: 10.1080/03007995.2018.1552407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
82 Samarasena J, Lee D, Chang KJ. Radiofrequency Ablation of Barrett’s Esophagus. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_16] [Reference Citation Analysis]
83 Krishnan K, Komanduri S. Endoscopic Mucosal Resection for Barrett’s-Related Neoplasia. The SAGES Manual of Foregut Surgery 2019. [DOI: 10.1007/978-3-319-96122-4_29] [Reference Citation Analysis]
84 Zhang B, Wu Q, Zhou YL, Xu R. The Best Surveillance Intervals for Detection of Intestinal Metaplasia and Dysplasia after Successful Endoscopic Eradication Therapy of Barrett's Esophagus. Am J Gastroenterol 2018;113:1904-5. [PMID: 30337702 DOI: 10.1038/s41395-018-0276-4] [Reference Citation Analysis]
85 Subramaniam S, Kandiah K, Thayalasekaran S, Longcroft-Wheaton G, Bhandari P. Haemostasis and prevention of bleeding related to ER: The role of a novel self-assembling peptide. United European Gastroenterol J. 2019;7:155-162. [PMID: 30788128 DOI: 10.1177/2050640618811504] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
86 Feczko AF, Louie BE. Endoscopic Resection in the Esophagus. Thorac Surg Clin 2018;28:481-97. [PMID: 30268294 DOI: 10.1016/j.thorsurg.2018.07.006] [Reference Citation Analysis]
87 Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol 2018; 24(35): 3965-3973 [PMID: 30254401 DOI: 10.3748/wjg.v24.i35.3965] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
88 Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc 2018; 10(9): 165-174 [PMID: 30283599 DOI: 10.4253/wjge.v10.i9.165] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
89 Visrodia K, Zakko L, Wang KK. Mucosal Ablation in Patients with Barrett's Esophagus: Fry or Freeze? Dig Dis Sci 2018;63:2129-35. [PMID: 29777441 DOI: 10.1007/s10620-018-5064-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
90 Seewald S, Ang TL, Pouw RE, Bannwart F, Bergman JJ. Management of Early-Stage Adenocarcinoma of the Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Dig Dis Sci 2018;63:2146-54. [PMID: 29934725 DOI: 10.1007/s10620-018-5158-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
91 Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20:71. [PMID: 30058019 DOI: 10.1007/s11912-018-0713-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
92 Inadomi J, Alastal H, Bonavina L, Gross S, Hunt RH, Mashimo H, di Pietro M, Rhee H, Shah M, Tolone S, Wang DH, Xie SH. Recent advances in Barrett's esophagus. Ann N Y Acad Sci 2018;1434:227-38. [PMID: 29974975 DOI: 10.1111/nyas.13909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
93 Read MD, Krishnadath KK, Clemons NJ, Phillips WA. Preclinical models for the study of Barrett's carcinogenesis. Ann N Y Acad Sci 2018;1434:139-48. [PMID: 29974961 DOI: 10.1111/nyas.13916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
94 Sawas T, Iyer PG, Alsawas M, Cotton CC, Leggett CL, Murad MH, Wang KK, Shaheen NJ, Katzka DA. Higher Rate of Barrett's Detection in the First Year After Successful Endoscopic Therapy: Meta-analysis. Am J Gastroenterol 2018;113:959-71. [PMID: 29899439 DOI: 10.1038/s41395-018-0090-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
95 Thota PN, Arora Z, Dumot JA, Falk G, Benjamin T, Goldblum J, Jang S, Lopez R, Vargo JJ. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer. Dig Dis Sci 2018;63:1311-9. [PMID: 29524114 DOI: 10.1007/s10620-018-5009-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
96 Yang D, Forde JJ, Draganov PV. Response. Gastrointest Endosc 2018;87:1369. [PMID: 29655444 DOI: 10.1016/j.gie.2018.01.022] [Reference Citation Analysis]
97 Li P, Li W, Gong S. Endoscopic submucosal dissection for early Barrett's esophagus neoplasia. Gastrointest Endosc 2018;87:1368. [PMID: 29655443 DOI: 10.1016/j.gie.2018.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
98 Komanduri S, Muthusamy VR, Wani S. Controversies in Endoscopic Eradication Therapy for Barrett's Esophagus. Gastroenterology 2018;154:1861-1875.e1. [PMID: 29458152 DOI: 10.1053/j.gastro.2017.12.045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
99 Yang D, Draganov PV. Endoscopic submucosal dissection compared to endoscopic mucosal resection for early Barrett esophagus neoplasia. Techniques in Gastrointestinal Endoscopy 2018;20:82-90. [DOI: 10.1016/j.tgie.2018.02.001] [Reference Citation Analysis]
100 Wani S, Qumseya B, Sultan S, Agrawal D, Chandrasekhara V, Harnke B, Kothari S, McCarter M, Shaukat A, Wang A, Yang J, Dewitt J; Standards of Practice Committee. Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer. Gastrointest Endosc 2018;87:907-931.e9. [PMID: 29397943 DOI: 10.1016/j.gie.2017.10.011] [Cited by in Crossref: 105] [Cited by in F6Publishing: 107] [Article Influence: 21.0] [Reference Citation Analysis]
101 Vermeulen BD, Siersema PD. Esophageal Stenting in Clinical Practice: an Overview. Curr Treat Options Gastroenterol. 2018;16:260-273. [PMID: 29557070 DOI: 10.1007/s11938-018-0181-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
102 Gaddam S. Prediction of Barrett's esophagus: are we there yet? Dis Esophagus 2018;31. [PMID: 29346553 DOI: 10.1093/dote/dox147] [Reference Citation Analysis]
103 Das KK, Falk GW. Long-term outcomes for cryotherapy in Barrett's esophagus with high-grade dysplasia: just cracking the ice. Gastrointest Endosc 2017;86:633-5. [PMID: 28917343 DOI: 10.1016/j.gie.2017.03.1540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
104 Hamade N, Sharma P. Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times. Curr Gastroenterol Rep 2017;19:48. [PMID: 28819902 DOI: 10.1007/s11894-017-0589-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
105 Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. [PMID: 28748917 DOI: 10.1038/nrdp.2017.48] [Cited by in Crossref: 390] [Cited by in F6Publishing: 438] [Article Influence: 65.0] [Reference Citation Analysis]
106 Eluri S, Shaheen NJ. Endoscopic Eradication Therapy in Barrett's Esophagus. Tech Gastrointest Endosc. 2017;19:137-142. [PMID: 29269998 DOI: 10.1016/j.tgie.2017.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
107 Yamashita DT, Li C, Bethune D, Henteleff H, Ellsmere J. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma: a Canadian experience. Can J Surg 2017;60:129-33. [PMID: 28338468 DOI: 10.1503/cjs.013515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
108 Xian W, McKeon F. Barrett's Stem Cells as a Unique and Targetable Entity. Cell Mol Gastroenterol Hepatol 2017;4:161-4. [PMID: 28593188 DOI: 10.1016/j.jcmgh.2017.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
109 Ning B, Abdelfatah MM, Othman MO. Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer. Ann Cardiothorac Surg. 2017;6:88-98. [PMID: 28446997 DOI: 10.21037/acs.2017.03.15] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]